Patient Safety Capsules
Covid patients at higher risk of serious neurodegenerative disorders: Study
June 28, 2022 : COVID-19 positive outpatients are at a far increased risk of neurodegenerative disorders compared with those who tested negative for the SARS-CoV-2 virus, according to a study. The researchers found that those who had tested positive for COVID-19 were at a much higher risk of Alzheimer’s disease, Parkinson’s disease, and ischaemic stroke.
Central govt in talks with UAE to recognise Indian Pharmacopoeia
Mumbai, June 29, 2022: The Central government is in talks with the United Arab Emirates (UAE) to include Indian Pharmacopoeia (IP) in the standards of pharmaceuticals authorized in UAE with an aim to boost export of Indian drugs to the Emirates.
Drug Laws & Policy Injections
CDSCO issues alert on batches of peripheral stent from US-based CordisNew Delhi, June 29, 2022: The Central Drug Standard Control Organisation (CDSCO) has issued a medical devices alert on certain batches of peripheral stent manufactured by US-based medical technology firm Cordis following the company raised alarm on the increasing complaint rate for the product.
AKCDA appeals to traders to boycott corporate entities in medical business Chennai, June 28, 2022: The All Kerala Chemists and Druggists Association (AKCDA) has appealed to its members not to support and cooperate with the emerging corporate entities in the medicine business to help them establish a foothold in the medicine market in Kerala.
PCI planning to start patient counselling to help pharmacists fight e-pharmaciesNew Delhi, June 27, 2022 : The Pharmacy Council of India (PCI) is planning to start patient counselling in collaboration with major pharmacy stores in the country in order to bring in a differentiation to the services pharmacists can offer and to win the threat of e-pharmacies.
DCGI approves indigenous mRNA Covid jab for emergency use in 18 yrs & above; Covovax for 7-11 yrsNew Delhi, June 28, 2022: The Drugs Controller General of India (DCGI) on Tuesday approved India’s first indigenously developed mRNA vaccine against COVID-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use for those aged 18 years and above, official sources said on Tuesday.
Regulatory checks on pharmaceutical products stringent, say former CDSCO membersJune 27, 2022: The regulatory processes involving pharmaceutical products are quite stringent, said former members of the Central Drugs Standard Control Organization's (CDSCO) subject expert committee (SEC) on endocrinology and metabolism.
Drug manufacturers hail draft Rule mandating QR code on packaging of top 300 brands of drugsMumbai, June 24, 2022: Drug manufacturers have hailed the draft Rule released by the Central government making Quick Response (QR) codes mandatory on the packaging of 300 life-saving drugs from May 1, 2023, saying that it will help trace source and affirm authenticity of drugs while also improving patient health and safety.
Pharma Injections
SEC recommends protocol amendment for GSK's stalled RSV maternal vaccine trialNew Delhi, June 24, 2022: The Subject Expert Committee (SEC) for Vaccines, which review proposals and advice Drugs Controller General (India) in matters for biologicals, has recommended approval of protocol amendment request from UK-based GSK for its stalled respiratory syncytial virus (RSV) maternal vaccine trial.
Domestic pharma sale declines 6.3% for second consecutive month in rowMumbai, June 25, 2022: The domestic pharma retail market has witnessed 6.3 per cent decline in May as compared to the same month last year. This is the second consecutive month-on-month decline indicating a slowdown in the overall industry growth. The pharma market went down 9 per cent in April this year.
Dermatology sector set to boom in the post Covid-19 market New Delhi, June 28, 2022: The dermatology sector in India is set to boom as people are facing factors such as lifestyle changes, environmental changes, pollution, and also short term factors like heat, humidity and pollution
NBFCs & FinTech platforms’ foray into medical financing space change landscape of patient care expenses Bengaluru, June 15, 2022: Non-Banking Financial Companies (NBFCs) and FinTech platforms are seen to bolster the medical loan ecosystem. These companies are seen to partner with healthcare providers to provide better access to affordable credit for patient care.
Exempt cheap drugs from price control, say Indian Pharmaceutical Alliance June 27, 2022: Indian Pharmaceutical Alliance (IPA) - the industry body that represents large domestic pharmaceutical companies has sought the government to exclude low-priced scheduled products from price control citing viability issues in the wake of high raw material and logistics costs.
Typhoid bacteria more resistant to antibiotics now: Lancet study June 22, 2022: Typhoid-causing bacteria have increasingly become resistant to critically important antibiotics like quinolone, and have spread widely over the past 30 years, according to the study published in the Lancet, which also said that quinolone-resistant strains in India increased to more than 95% in the 2000s.
Drug Dopes
AKCDA plans to enter online business space, launching Youtube Channel to educate tradersChennai, June 25, 2022: The annual general body meeting of the All Kerala Chemists and Druggists Association (AKCDA) to be held at Hotel Abad Plaza in Kochi on June 26, is likely adopt a resolution to enter into e-pharma sector by uniting all its network agencies including wholesalers and retailers operating across the country. 
Blood-based neuronal exosome method would be a game-changer to detect dementia: VS MandaBengaluru, June 25, 2022: India faces dearth of early diagnostics for neuro-inflammatory disorders. The current test methods are a combination of imaging such as MRI/PET-CT, psychological monitoring, clinical interviews, and a few biochemical tests to detect Alzheimer's, dementia and other neurodegenerative diseases, said Venakata Sasidhar Manda, chief scientific officer, AHERF, founder, Urvogelbio.
PAMM to support and join Pharmac South to showcase its products & services Chennai, June 24, 2022: Expecting that the diverse range of audience planning to visit the pharmaceutical expo in July in Chennai will create a new environment for promoting their products, the Pharmaceutical Association of Marketers and Manufacturers (PAMM), the new marketers’ body floated by pharma marketers in Tamil Nadu, has decided to fully support and join the trade show, Pharmac South 2022.
We are able to predict pandemic based on changes in virus, other signals: Bharat Biotech founder Mumbai, June 16, 2022: Covaxin maker Bharat Biotech founder on Thursday said that his company is now able to predict a pandemic based on changes in virus and related signals.
Aurobindo Pharma receives warning from SEBI for non-disclosures related to USFDA audit PTI, June 28, 2022: Rugmaker Aurobindo Pharma on Monday told stock exchanges that it has received a "warning letter" from the Securities and Exchange Board of India (SEBI) alleging lack of sufficient disclosures involving the audit by the USFDA at its Unit-I. an API (Active Pharmaceutical Ingredients) manufacturing in Hyderabad.
SII’s qHPV vaccine will improve affordability and penetration: GlobalDataNew Delhi, June 24, 2022: A possible approval of Serum Institute of India’s (SII) Cervavac—a quadrivalent human papillomavirus (qHPV) vaccine will not only make the drug more affordable to Indians, but it will significantly improve the overall penetration and help address the growing number of cervical cancer cases in the country, says data and analytics company GlobalData.
National Injections
IPA calls nutraceutical, pharma industries to join hands to provide holistic care Mumbai, June 27, 2022: Stating that India has gained over 19 years of life expectancy in a span of 60 years, leading to a significant rise in lifestyle diseases, the Indian Pharmaceutical Alliance (IP Alliance) has called nutraceutical and pharmaceutical industries to come together to provide holistic care to all.
Industry eyes 3D printing for manufacture as the future to spur easy fabrication of tablets with multiple APIsBengaluru, June 28, 2022 : Pharma industry eyes 3D printing technology for manufacture in the future as it allows easy fabrication of tablets with multiple APIs (active pharmaceutical ingredients). The key reasons for the pharma industry to take up 3D printing technology are that it is suitable for orphan drugs and personalized medicine, said Korinde van den Heuvel, senior product developer, DFE Pharma.
50 pc Delhi-NCR residents with Covid-like symptoms in last 30 days took no tests: NGO New Delhi, June 20, 2022: Despite a spike in coronavirus cases, a large number of people in Delhi and neighbouring cities in the last one month either refrained from undergoing tests or opted for a simple rapid antigen test after they showed Covid-like symptoms, a health NGO has claimed.
High input costs continue taking a toll on drug manufacturers Mumbai, June 27, 2022: A spurt in prices of raw materials imported from China along with a significant rise in freight, packaging material and transportation costs, in the wake of the Covid-19 pandemic, derailed the Indian pharmaceutical industry’s cost-effectiveness and expansion plans.
AMR Industry Alliance underscores need for antibiotic manufacturers to prevent aquatic eco-toxicity Bengaluru, June 27, 2022: The new Antibiotic Manufacturing Standard (AMS) developed by the AMR Industry Alliance is a critical step to implement responsible production practices to mitigate the impact of antimicrobial resistance (AMR) in the environment. Antibiotics are essential innovations saving lives. In the production of these medicines, emissions in manufacturing waste streams can lead to AMR.
Indian pharma gives impetus to technology as it propels efficiency in supply chain and inventory tracking Bengaluru, June 14, 2022: Indian pharma is giving an impetus to digital technology. The sector covering research, manufacture and retailing sees technology to propel efficiency across its gamut of services.
Global Injections
FDA Panel Backs Adding Omicron Component to COVID BoostersJune 28, 2022: A FDA advisory panel on Tuesday recommended updating COVID-19 booster vaccines in the United States to in-clude an Omicron component, while also stressing the need for more information on how well these shots work on emerging strains of the virus.
Monkeypox Not a Global Emergency Yet, WHO SaysJune 27, 2022: The World Health Organization said Saturday that the growing monkeypox outbreak in 50 countries should be watched closely but doesn’t yet warrant being declared a global public health emergency.
Juul: US bans all products from leading vaping company
June 24, 2022: The Food and Drug Administration (FDA) said it did not have enough data to be sure that marketing the firm's products was "appropriate for the protection of public health".
The world reacts to US abortion ruling
June 26, 2022: In 1978, five years after Roe v Wade, Italy legalised abortion with Law 194. And while it is not the same lightning rod political issue here, the rise of a new hard-right conservative politics, ever closer to the Catholic church, has brought it back into focus - and the US Supreme Court's decision is reverberating in Italy too.
Trial failure for Jazz’s cannabis-derived drug blunts goal to expand its use to US
June 28, 2022: Jazz Pharmaceuticals made its cannabis drug ambitions clear last year with a $7.2 billion acquisition of GW Pharmaceuticals and again in March when it started building a plant in the U.K. designed specifically for cannabis-based medicines.
Volume turns up on Decibel as hearing loss therapy protects patients in early-stage trial
June 28, 2022: A small data set but big improvement in the hearing loss brought on by chemotherapy was enough to send Decibel Therapeutics' shares soaring in premarket trading Tuesday.
PSAIIF PILL
IPA calls nutraceutical, pharma industries to join hands to provide holistic care
Mumbai, June 27, 2022: Stating that India has gained over 19 years of life expectancy in a span of 60 years, leading to a significant rise in lifestyle diseases, the Indian Pharmaceutical Alliance (IP Alliance) has called nutraceutical and pharmaceutical industries to come together to provide holistic care to all.
India emerged successfully in management of covid pandemic: Mansukh Mandaviya
June 25, 2022: Union Minister Mansukh Mandaviya on Saturday said the country has successfully spearheaded the fight against covid-19 pandemic under the leadership of Prime Minister Narendra Modi. The country also developed a “robust and strong mechanism to counter the public health issues,” he said. “The country has emerged successfully in the management of the pandemic,” the Health and Family Welfare minister said.
Frequently Asked Questions
How yoga and meditation can help you with divine healing of emotional traumas?
Yoga and meditation are ancient restorative sciences that can be used as therapies for the holistic heal-ing of the important triad of well-being, namely the mind, soul and body. To keep the body healthy, strengthen the mind and soothe the soul, nothing works better than these two divine practices. The world is waking up to their sterling benefits, and beginning to induct them in their own plans of daily well-being. During the COVID-19 pandemic, Yoga and meditation practitioners were quite successful in keeping the peace and going with the flow of the evolving times. Seeing this, several others too found themselves wanting to start or revert to these practices to get in touch with the peace within. Read More>>>
SUBSCRIBER'S SYMPTOM
Climate change worsening effect of seasonal allergies
June 28, 2022: Fresh outdoor air is always cleaner and better unless you are allergic to the budding blooms which can lead to runny nose, watery eyes, sneezing or wheezing. This is especially true when the pollen season is in full swing..
Consumer Online Foundation: The first and only organisation certified as per international standard ISO 9001:2015 for Consumer Complaint Redressal Services
First and the only organization in India to be certified on 21st September 2021 as an ISO 9001:2015 on Consumer Complaint Redressal Services. We are proud to share our achievements with our readers and supporters. Thanks for your continued support and guidance for more than 35+ years of service to the consumers in India and abroad.
Blog Addicts
Ms. Rohini, Medical Student, New Delhi Thank You @PSA-India! For delivering such an informative and interesting fortnightly newsletter, The Prescription.
Dr. Debasis Mohanthy, Physician, KolkataGreat Applause to PSA-India as they are efficiently promoting awareness against spurious medicine across the country.
Dr. Izra khan, MD, Lucknow
Thank You! PSA-India for helping the people to know their medication closely.
This Newsletter is brought to you by
Patient Safety And Access Initiative of India Foundation
B306, First Floor, C R Park, New Delhi -110019
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources .
PSAIIF may not be held responsible for any article published in The Prescription.
